Evidence map›Paper›PMID 39350289›Full record

ArticleMicrobiome2024

Stratification of human gut microbiomes by succinotype is associated with inflammatory bowel disease status.

Laura Anthamatten, Philipp Rogalla von Bieberstein, Carmen Menzi, Janina N Zünd, Christophe Lacroix, Tomas de Wouters, Gabriel E Leventhal

Abstract read
In one paragraph

Article in Microbiome, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. The impact ofFrontiers in cellular and infection microbiology · 2025
    Pooled it
  2. Bridging the gap:Gut microbes · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Gut · 2026
    Article
  12. Article
  13. Complete genomes ofMicrobiology resource announcements · 2026
    Article
  14. Review
  15. Article
  16. Review
  17. World journal of gastroenterology · 2025
    Article
  18. Article
  19. Polysaccharides fromFood chemistry: X · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Laura AnthamattenPharmaBiome AG, Schlieren, Switzerland.
Philipp Rogalla von BiebersteinPharmaBiome AG, Schlieren, Switzerland.ORCID 0000-0002-1391-3285
Carmen MenziPharmaBiome AG, Schlieren, Switzerland.ORCID 0000-0002-8656-3183
Janina N ZündLaboratory of Food Biotechnology, Institute of Food, Nutrition and Health, ETH Zurich, Zurich, Switzerland.ORCID 0009-0008-0687-8822
Christophe LacroixLaboratory of Food Biotechnology, Institute of Food, Nutrition and Health, ETH Zurich, Zurich, Switzerland.ORCID 0000-0003-4360-2020
Tomas de WoutersPharmaBiome AG, Schlieren, Switzerland. t.dewouters@pharmabiome.com.ORCID 0000-0002-4592-2338
Gabriel E LeventhalPharmaBiome AG, Schlieren, Switzerland. g.leventhal@pharmabiome.com.ORCID 0000-0002-4463-166X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe human gut microbiome produces and consumes a variety of compounds that interact with the host and impact health. Succinate is of particular interest as it intersects with both host and microbiome metabolism. However, which gut bacteria are most responsible for the consumption of intestinal succinate is poorly understood.

resultsWe build upon an enrichment-based whole fecal sample culturing approach and identify two main bacterial taxa that are responsible for succinate consumption in the human intestinal microbiome, Phascolarctobacterium and Dialister. These two taxa have the hallmark of a functional guild and are strongly mutual exclusive across 21,459 fecal samples in 94 cohorts and can thus be used to assign a robust "succinotype" to an individual. We show that they differ with respect to their rate of succinate consumption in vitro and that this is associated with higher concentrations of fecal succinate. Finally, individuals suffering from inflammatory bowel disease (IBD) are more likely to have the Dialister succinotype compared to healthy subjects.

conclusionsWe identified that only two bacterial genera are the key succinate consumers in human gut microbiome, despite the fact that many more intestinal bacteria encode for the succinate pathway. This highlights the importance of phenotypic assays in functionally profiling intestinal microbiota. A stratification based on "succinotype" is to our knowledge the first function-based classification of human intestinal microbiota. The association of succinotype with IBD thus builds a bridge between microbiome function and IBD pathophysiology related to succinate homeostasis. Video Abstract.

Indexed as

FecesGastrointestinal MicrobiomeInflammatory Bowel DiseasesSuccinic AcidAdultBacteriaFemaleHumansMaleRNA, Ribosomal, 16SRNA, Ribosomal, 16SSuccinic Acid

Identifiers

PMID39350289
PMCPMC11441152

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.